LOGIN  |  REGISTER
Assertio

Latest Medical Stock News

FILTER BY TOPIC:     Medical Devices   Diagnostics & Research   FDA 510(k) Clearance   Psychedelics        List of All Medical Stocks  

QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA

September 21
Last Trade: 71.82 -1.63 -2.22

SAN DIEGO / Sep 21, 2023 / Business Wire / QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it has been granted CLIA Waiver from the U.S. Food and Drug Administration (FDA), applying to its new Sofia® 2 SARS Antigen+ FIA. The Sofia 2 SARS Antigen+ FIA is the first rapid...Read more


Stryker's Triathlon Tritanium Baseplate marks a decade of positive patient impact

September 21
Last Trade: 284.31 -4.66 -1.61

Over 1 million Triathlon Cementless Knees implanted globally MAHWAH, N.J., Sept. 21, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's leading medical technology companies, continues its year of milestones celebration with the 10th anniversary of the Triathlon Tritanium baseplate. Since its introduction in 2013, Triathlon Cementless, which includes the Triathlon Tritanium Baseplate, has delivered a decade of positive...Read more


Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases

September 21
Last Trade: 1.42 -0.06 -4.05

SAN DIEGO / Sep 21, 2023 / Business Wire / Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces the full enrollment of 40 subjects with breast or non-small cell lung cancer (NSCLC) who have suspicious or confirmed leptomeningeal metastases (LM) in the feasibility phase of its prospective FORESEE clinical trial (NCT0414123). This trial is evaluating the performance of Biocept’s...Read more


Dexcom Canada and RxFood Partner on Industry-Leading, AI-powered Nutrition and Glucose Monitoring Solution for Diabetes Management and Personalized Therapeutic Nutrition

September 21
Last Trade: 89.08 -3.55 -3.83

The partnership will pair cutting-edge technology from Dexcom with daily food tracking to provide a more comprehensive and personalized care experience for those living with diabetes BURNABY, British Columbia / Sep 21, 2023 / Business Wire / Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, and RxFood Corporation, the leader in AI-driven personalized nutrition...Read more


Medtronic Diabetes announces CE Mark for new Simplera™ CGM with disposable all-in-one design

September 21
Last Trade: 80.46 -1.02 -1.25

The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience DUBLIN, Sept. 21, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced CE (Conformité Européenne) Mark approval for its new all-in-one, disposable Simplera™ continuous glucose monitor (CGM) featuring a simple, two-step insertion process....Read more


Digital Dentistry: Dentsply Sirona and 3Shape expand their workflow integrations

September 21
Last Trade: 34.16 -1.03 -2.93

Dentsply Sirona and 3Shape are expanding their workflow integrations to enable dental professionals through DS Core and 3Shape Unite to use a scan-to-lab workflow or establish design and manufacturing protocols directly in their practice. CHARLOTTE, N.C. and COPENHAGEN, Denmark, Sept. 21, 2023 /PRNewswire/ -- Dentsply Sirona, the world's largest manufacturer of professional dental products and technologies, and 3Shape, a...Read more


Bionano Genomics Announces Third OEM Partner has Received China NMPA Approval for DNA Isolation Products for IVD Use of OGM

September 21
Last Trade: 2.98 -0.02 -0.67

Bionano original equipment manufacturing (OEM) partner Ecobono obtained reagent Class I registration and approval for Bionano’s DNA isolation kits for optical genome mapping (OGM) from China's National Medical Products Administration (NMPA) Reagents can be utilized for in vitro diagnostics (IVD) use in China With this NMPA registration, Ecobono can sell OGM reagents to independent clinical laboratories and Chinese...Read more


HeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular Algorithms

September 21
Last Trade: 0.37 -0.0074 -1.94

Southlake, TX, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an AI-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced it has executed definitive agreements with the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai), in New York, NY, to...Read more


ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System

September 21
Last Trade: 0.61 -0.06 -9.33

IRVINE, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the signing of an exclusive, royalty-bearing license agreement with Biorad Medysis, Pvt. Ltd. (Biorad) to manufacture, commercialize and distribute the Obalon® Gastric Balloon System in India, Pakistan, Bangladesh, Nepal, Bhutan, Sri Lanka, and the...Read more


LeMaitre Vascular to Present at the 2023 Cantor Global Healthcare Conference

September 21
Last Trade: 57.03 -0.46 -0.80

BURLINGTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at 2023 Cantor Global Healthcare Conference on Tuesday, September 26, 2023, at 11:40 AM ET in New York City. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people...Read more


AVITA Medical to Present at the Cantor Global Healthcare Conference

September 21
Last Trade: 13.86 -0.28 -1.98

VALENCIA, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announced that Jim Corbett, Chief Executive Officer, will present at the 2023 Cantor Fitzgerald Global Healthcare Conference in New York on Tuesday, September 26, 2023, at 11:05...Read more


Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13

September 21
Last Trade: 9.89 -0.02 -0.20

TORONTO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will host an Analyst & Investor Day event on Friday, October 13, 2023 from 1:00 p.m. to approximately 3:30 p.m. Eastern Time. “The program will feature presentations on...Read more


Sera Prognostics To Present At Cantor Fitzgerald Global Healthcare Conference 2023

September 21
Last Trade: 1.78 -0.05 -2.73

SALT LAKE CITY, Sept. 21, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will present at the upcoming Cantor Fitzgerald Global Healthcare Conference 2023 to be held September 26-28, 2023 in New York City. Zhenya Lindgardt, Sera's interim...Read more


electroCore to Present at iAccess Alpha’s – Top 10 Best Ideas from the Buyside Virtual Conference

September 21
Last Trade: 5.49 0.05 0.92

ROCKAWAY, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will present at iAccess Alpha’s – Top 10 Best Ideas from the Buyside Virtual Conference. Mr. Goldberger will also be available for one-on-one meetings held throughout the conference on September 26 and 27, 2023. iAccess Alpha’s – Top 10 Best...Read more


Intelligent Bio Solutions Successfully Debuts Intelligent Fingerprinting Drug Screening Solution at the 2023 Workplace Health & Safety Show in Sydney, Australia

September 21
Last Trade: 1.27 0.05 4.09

NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful debut of its Intelligent Fingerprinting Drug Screening System at the 2023 Workplace Health & Safety Show in Sydney, Australia on September 20th and 21st. The non-invasive, portable system is...Read more


Helius Medical Technologies to Bring its Innovative PoNS Therapy for Improvement of Gait in People with MS, to the 2023 Academy of Neurologic Physical Therapy Conference

September 21
Last Trade: 8.67 0.09 1.05

Company’s First-Ever ANPT Booth Sponsorship Enables Specialists to Learn More about this Breakthrough Technology on Eve of National Physical Therapy Month NEWTOWN, Pa., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that it will exhibit...Read more


ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations

September 21
Last Trade: 1.00 0.03 3.06

PLEASANTON, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (“OSA”), today announced the completion of a $10 million convertible preferred equity offering led by existing investors Spring Mountain Capital and Cetus Capital, LLC. ProSomnus’s Executive Chair, Chief Executive Officer, and Chief Financial Officer are...Read more


Psychemedics Appoints Shannon Shoemaker as Chief Revenue Officer

September 21
Last Trade: 3.66 -0.07 -1.88

ACTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world’s largest provider of hair testing for drugs of abuse, is pleased to announce the appointment of Shannon Shoemaker as its new Chief Revenue Officer. In this role, Shoemaker will be responsible for overseeing the company's revenue generation and growth strategies. With an exceptional track record of leadership and a strong background in revenue growth and...Read more


Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors

September 21
Last Trade: 1.98 -0.03 -1.49

BRANFORD, Conn. / Sep 21, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Amir Jafri, President and CEO of Immunicom, Inc., to its Board of Directors. “Amir’s leadership track record speaks for itself,” said Jeff Hawkins, CEO of Quantum-Si. “He has successfully managed businesses across multiple industries and has built...Read more


Femasys Announces First-Patient-In for Pivotal Clinical Trial Evaluating its FemBloc Permanent Birth Control

September 20
Last Trade: 0.31 -0.02 -4.93

ATLANTA, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including two lead revolutionary late-clinical stage product candidates and FDA-cleared, innovative diagnostic products, today announced the achievement of First-Patient-In for its pivotal clinical trial evaluating FemBloc®, a...Read more


Abbott Broadens Access to Cutting-Edge Biosimilars in Key Emerging Markets

September 20
Last Trade: 98.93 -1.35 -1.35

Abbott to commercialize several biosimilar molecules in key emerging markets in Latin America, Southeast Asia, the Middle East and Africa Spain-based global biotech leader mAbxience Holdings S.L. to develop, manufacture and supply the biosimilar molecules First molecules expected to launch as early as 2025, offering new treatment options that leverage the latest in scientific breakthroughs for people in emerging markets ABBOTT...Read more


Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological Therapies

September 20
Last Trade: 268.78 -5.33 -1.94

News Summary: New Zeta Star™ instrument for nanoparticle analysis from Wyatt Technology™ portfolio combines three light scattering techniques into a single device – cutting measurement time by up to 10x[i] over other methods. Measures biologic drug products at extremely low sample volumes to determine five critical parameters within one workflow, increasing efficiency, and also improves confidence in results. ZetaStar instrument...Read more


ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution

September 20
Last Trade: 251.87 -9.91 -3.79

Solution seamlessly delivers proprietary technology, real world data and analytics, aligning to industry security and data privacy standards DUBLIN / Sep 20, 2023 / Business Wire / ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces the release of its next generation Clinical Trial Tokenisation solution. The combination of ICON’s proprietary tokenisation engine, access to...Read more


Orthofix Medical Announces First Patient Procedures and Full Commercial Launch of the Galaxy Fixation Gemini System and Expanded Sterile Kit Offerings for Orthopedic Trauma Procedures

September 20
Last Trade: 12.70 -0.03 -0.24

LEWISVILLE, Texas / Sep 20, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full U.S. commercial launch and successful completion of the first cases with the Galaxy Fixation Gemini™ system. The latest in the Galaxy product line, this stable external fixation system is provided in several sterile procedure kit configurations as a quick off-the-shelf solution for...Read more


IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer

September 20
Last Trade: 0.66 0.09 14.78

CAESAREA, Israel, Sept. 20, 2023 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that the U.S. Food and Drug Administration ("FDA") has at this time denied the Company's De Novo Classification request for breast cancer which was submitted based on interim...Read more


BrainsWay Broadens Access to Deep TMS™ for U.S. Military Service Members Through Expanded Partnership with Katie’s Way Plus

September 20
Last Trade: 4.26 -0.35 -7.59

BURLINGTON, Mass. and JERUSALEM, Sept. 20, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that its longstanding partner, Katie’s Way Plus, which provides comprehensive mental health services tailored to the unique needs of active duty military members, veterans, and their...Read more


NuGen Medical Devices Completes Delivery and First Sale of 500 InsuJet(TM) Devices and Consumables in Romania

September 20
Last Trade: 0.10 -0.01 -9.52

Toronto, Ontario--(Newsfile Corp. - September 20, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to report it has completed the delivery and sale of the first 500 units of the Company's needle-free InsuJet™ injector device and consumables to SC Trustmed SRL ("Trustmed") in Romania as previously announced on June 12th, 2023. The sale, although small in size, was completed earlier than anticipated and...Read more


Helius Medical Technologies: University of Montreal’s School of Rehabilitation to Purchase Ten PoNS® Devices for Research Study on Stroke Recovery

September 20
Last Trade: 8.67 0.09 1.05

NEWTOWN, Pa., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced it has signed an agreement with the School of Rehabilitation at the Université de Montréal (“UdeM”) for the purchase of ten PoNS devices to be used in a research project linked to...Read more


Charles River Laboratories to Host Virtual Investor Day

September 20
Last Trade: 198.18 -10.45 -5.01

WILMINGTON, Mass. / Sep 20, 2023 / Business Wire / Charles River Laboratories International, Inc. (NYSE: CRL) announced that it will host a virtual Meeting with Management on Thursday, September 21st, beginning at 8:30 a.m. ET. This virtual event will feature presentations from its senior management team, including an overview of the Company’s strategic focus, business developments, and updated financial targets, with a focus on the...Read more


Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe

September 20
Last Trade: 6.40 0.07 1.11

FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, is furthering its mission to advance the next generation of high parameter cell analysis by continuing to have an active presence at key industry events worldwide. The company’s Full Spectrum Profiling™ (FSP™) technology that streamlines workflows, accelerates discoveries and maximizes efficiency will be...Read more


Treace Medical Concepts Highlights New Product Innovations and Updated ALIGN3D™ Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2023

September 20
Last Trade: 13.43 -0.46 -3.31

PONTE VEDRA, Fla., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction® Procedure, today announced it will highlight new product innovations and present new interim data for the ALIGN3D™ clinical study at the...Read more


Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference 

September 20
Last Trade: 3.15 -0.10 -3.08

BERKELEY, Calif. and MAINZ, Germany, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that Guido Baechler, Chief Executive Officer, will present at the Cantor Fitzgerald Global Healthcare Conference which takes place September 26-28, 2023 in New York City. This year’s conference is...Read more


Atrion Announces Election of New Director

September 20
Last Trade: 440.98 -3.05 -0.69

ALLEN, Texas, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) announced the election today of Jeannette Bankes as a director, effective immediately. Ms. Bankes brings to our Board over 32 years of experience at major medical device and pharmaceutical companies. Since March 2019, Ms. Bankes has served as the President and General Manager of the Global Surgical Franchise at Alcon Inc. From August 2004 to March 2019,...Read more


Great Elm Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results

September 20
Last Trade: 2.12 -0.06 -2.75

WALTHAM, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Great Elm Group, Inc. (“we,” “our,” “GEG,” “Great Elm,” or “the Company”), (NASDAQ: GEG), an alternative asset manager, today announced financial results for its fiscal fourth quarter and year ended June 30, 2023. Fiscal Fourth Quarter 2023 Highlights GEG collected incentive fees from Great Elm Capital Corp. (“GECC") for the first time in the Company’s history, totaling $1.0 million...Read more


T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat Panel

September 19
Last Trade: 0.29 -0.01 -3.94

LEXINGTON, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the T2Biothreat™ Panel. The FDA 510(k) clearance allows the company to immediately begin marketing and selling the T2Biothreat Panel in the U.S....Read more


Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions

September 19
Last Trade: 284.31 -4.66 -1.61

Stryker’s PROstep MIS portfolio will be featured at the American Orthopaedic Foot & Ankle Society Annual Meeting KALAMAZOO, Mich. / Sep 19, 2023 / Business Wire / Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced the launch of PROstep® MIS Lapidus, a new internal fixation system intended for treating bunions using a minimally invasive surgical reduction of hallux valgus deformity and subsequent...Read more


Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund at Cost

September 19
Last Trade: 249.62 -4.84 -1.90

New agreement aims to provide greater access to millions more high-quality tuberculosis (TB) tests for people living in the least developed countries where the need is most urgent. Enables the Global Fund to provide Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges for TB at cost, with no profit to Danaher. WASHINGTON, Sept. 19, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology...Read more


Boston Scientific Announces Agreement to Acquire Relievant Medsystems

September 19
Last Trade: 53.98 -0.12 -0.22

Acquisition intended to expand neuromodulation portfolio to provide more treatment options for people living with chronic low back pain MARLBOROUGH, Mass., Sept. 19, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept® Intraosseous...Read more


Abbott and WeightWatchers Connected App Experience is Now Available for People Living with Diabetes

September 19
Last Trade: 98.93 -1.35 -1.35

The #1 prescribed continuous glucose monitoring (CGM) system1 now connects to the #1 doctor-recommended weight management plan2 to help people living with diabetes understand how food and activity impact their glucose levels WeightWatchers Diabetes-Tailored Plan members can now see key glucose data3,4,5 from Abbott's FreeStyle Libre® 2 system within the WW app6 ABBOTT PARK, Ill. and NEW YORK, Sept. 19, 2023 /PRNewswire/ --...Read more


Canadian First - Abbott's TactiFlex™ Ablation Catheter Used to Treat AFib

September 19
Last Trade: 98.93 -1.35 -1.35

Abbott introduced the world's first ablation catheter with a flexible tip and contact force technology, used to perform an ablation procedure to treat atrial fibrillation (AFib) First successful treatment in Canada - Abbott's innovative technology enables physicians to have better visualization allowing for more accuracy and precision, leading to reduced procedure times and better safety MISSISSAUGA, ON, Sept. 19, 2023 /CNW/ --...Read more


Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

September 19
Last Trade: 16.77 -0.23 -1.35

SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted therapies. Under the strategic partnership, Myriad and Illumina are...Read more


Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.

September 19
Last Trade: 14.59 -0.16 -1.08

UPPSALA, Sweden, September 19, 2023 (GLOBE NEWSWIRE) – Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink® Target 48 Mouse Cytokine Panel, a validated multiplexed protein panel that offers a detailed view of the murine immune system, enabling in-depth disease modelling, longitudinal studies and translational research. The Olink Target 48 Mouse Cytokine Panel represents a new standard in immunoassays giving...Read more


Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms

September 19
Last Trade: 4.38 -0.07 -1.57

PhenoCycler-Fusion 2.0 enhancements enable the highest throughput workflow for spatial discovery studies. PhenoImager HT 2.0 delivers a 5x greater speed improvement for spatial studies in translational and clinical research. MARLBOROUGH, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today highlighted the industry-leading scale and speed in whole-slide,...Read more


DermTech Announces Contracts With Highmark for the Foundational Assay of Its DermTech Melanoma Test (DMT)

September 19
Last Trade: 1.70 0.01 0.59

SAN DIEGO / Sep 19, 2023 / Business Wire / DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced agreements with Highmark Inc. (Highmark). The contracts, which are in addition to a favorable coverage policy, enhance access to the foundational assay of the DermTech Melanoma Test (DMT). Highmark and its Blue-branded affiliates provide...Read more


bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services

September 19
Last Trade: 1.06 -0.48 -31.17

Transformative Strategic Transaction Supports Commercialization of CyPath® Lung Precision Pathology Founder Dr. Roby Joyce Joins bioAffinity’s Board of Directors Conference Call at 4:30 p.m. Eastern time Today SAN ANTONIO, Texas / Sep 19, 2023 / Business Wire / bioAffinity Technologies, Inc. (Nasdaq: BIAF, BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, announces the...Read more


ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon System

September 19
Last Trade: 0.61 -0.06 -9.33

IRVINE, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the company has significantly strengthened the patent portfolio related to its Obalon® Balloon System. Specifically, the U.S. Patent and Trademark Office (USPTO) has granted one patent and provided the company with a Notice of Allowance for two...Read more


Align Technology Connects With Over 1,000 Doctors and Practice Staff at the 2023 Invisalign™ GP Summit Where Leaders in Digital Orthodontics and Restorative Dentistry Share Best Practices for Leading Transformation in Dentistry

September 19
Last Trade: 300.28 -9.22 -2.98

Company Features Latest Innovations Across the Align Digital Platform™ Designed to Provide a Seamless Experience and Workflow that Integrates and Connects all Users – Doctors, Labs, Patients, and Consumers LAS VEGAS & SAN JOSE, Calif. & TEMPE, Ariz. / Sep 19, 2023 / Business Wire / Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign System...Read more


Zynex to Present at the Cantor Global Healthcare Conference

September 19
Last Trade: 8.37 0.34 4.23

ENGLEWOOD, Colo., Sept. 19, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will present at the upcoming Cantor Global Healthcare Conference, which is being held September 26th-28th, 2023. Zynex's presentation will be held in person and webcast...Read more


Bioventus to Present at the Cantor Global Healthcare Conference

September 19
Last Trade: 2.91 -0.16 -5.21

DURHAM, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief financial officer, will participate in a fireside chat at the Cantor Global Healthcare Conference on Thursday, September 28, 2023, at 1:50 p.m. ET. A live audio webcast of the fireside chat will be available on the “Investors” section of the...Read more


CareDx To Present at the 2023 Cantor Global Healthcare Conference

September 19
Last Trade: 7.75 -0.09 -1.15

BRISBANE, Calif. / Sep 19, 2023 / Business Wire / CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in the 2023 Cantor Global Healthcare Conference. CareDx’s management is scheduled to present at the 2023 Cantor...Read more


Elutia Announces Private Placement for Proceeds Up to $26 Million

September 19
Last Trade: 1.53 0.00 0.00

Combined proceeds of financing and Orthobiologics divestiture potentially top $60 million SILVER SPRING, Md., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today announced that it has entered into a securities purchase agreement for a private placement (PIPE) financing that is expected to result in initial gross proceeds to the Company of approximately...Read more


CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer

September 19
Last Trade: 2.02 0.01 0.50

PRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, announced the re-appointment of Kathleen P. Bloch as full-time Chief Financial Officer, effective retroactively to September 2, 2023. Ms. Bloch...Read more


Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder

September 18
Last Trade: 2.80 -0.03 -1.06

New data demonstrates a therapeutic effect for at least 10 days after a single subcutaneously (SC) injection of an extended-release selective neuronal nitric oxide synthase (nNOS) inhibitor The slow-release formulation led to reversal of behavioral phenotypes and the nitrosative stress of the Shank3 mouse model of autism. GARDEN CITY, N.Y., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the...Read more


Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million

September 18
Last Trade: 1.53 0.00 0.00

Transaction Reflects Increasing Strategic Focus on Proprietary Drug-Eluting Biomatrix Platform SILVER SPRING, Md., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today announced the divestiture of the Company’s Orthobiologics business unit to Berkeley Biologics LLC, a wholly owned subsidiary of GNI Group Ltd. Elutia will receive cash proceeds of up to...Read more


Myriad Genetics and Leading Cancer Center Collaborate to Study the Use of Minimal Residual Disease Testing in Breast Cancer

September 18
Last Trade: 16.77 -0.23 -1.35

SALT LAKE CITY, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK) to study the use of minimal residual disease (MRD) testing in breast cancer. The research project will use Myriad’s MRD testing platform, a tumor-informed high-definition assay that uses whole-genome sequencing to...Read more


Bruker Introduces Novel 4D-Proteomics™ timsTOF® Capabilities

September 18
Last Trade: 62.18 -1.98 -3.09

New AI-powered TIMSquant™ software for CCS-enabled, label-free quantification scalable to thousands of samples Early midia-PASEF® access for immunopeptidomics and PTMs on ultra-sensitive timsTOF Ultra for DDA-like precursor traceability in dia-PASEF Affordable, high-throughput ~3,500 PG plasma proteomics on timsTOF HT with PreOmics ENRICH kit using Biognosys Spectronaut® 18 directDIA+™ software New PepSep™ ULTRA XL and MAX HT nano-LC...Read more


New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy

September 18
Last Trade: 19.52 -0.50 -2.50

Publications Show Reductions in Hospital Resource Utilization Associated with 10 kHz Therapy Spinal Cord Stimulation for the Treatment of Painful Diabetic Neuropathy and Nonsurgical Refractory Back Pain REDWOOD CITY, Calif., Sept. 18, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced the...Read more


Accuray Opens New Global Training Center at Madison, WI Headquarters to Advance Radiotherapy Treatment Techniques Amid Growing Demand for Precision Cancer Care

September 18
Last Trade: 2.70 -0.04 -1.46

Large classrooms and a hybrid, in-person/remote connection option will make it easier for more care providers to remain current on best practices and innovations in radiation therapy New center is part of the company's comprehensive education program which also includes on-site training, online microlearning and cloud-hosted courses, as well as Accuray Exchange, a platform for peer-to-peer exchange MADISON, Wis., Sept. 18, 2023...Read more


Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research

September 18
Last Trade: 4.12 0.02 0.49

Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI) Expands reach of unique, non-invasive wearable monitoring for pre-clinical research across North American and European markets HOLLISTON, Mass. and LYON, France, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) and Etisense announced today that they have entered into an agreement to offer...Read more


908 Devices Launches MAVERICK for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters

September 18
Last Trade: 6.00 -0.04 -0.66

MAVERICK is a Raman-based PAT solution that requires no complex modeling BOSTON / Sep 18, 2023 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the launch of MAVERICK, an optical in-line analyzer that provides real-time monitoring and control of glucose, lactate, and total biomass in mammalian cell cultures, in addition to rich...Read more


Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device

September 18
Last Trade: 11.18 -2.61 -18.93

REDWOOD CITY, CA / ACCESSWIRE / September 18, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced full commercial launch of its Tigereye® ST next generation image-guided chronic total occlusion (CTO) crossing system. With the initiation of full commercial launch, all...Read more


Ocumetics Technology Continues to Meet Significant Development Milestones; Lens Design Optimized for Upcoming First in Human Study

September 18
Last Trade: 0.31 0.00 0.00

Calgary, Alberta – September 18, 2023.  Ocumetics Technology Corp. (“Ocumetics”) (TSXV:OTC) (OTC:OTCFF) (FRA:2QBO), a pioneer in in the field of ophthalmic innovation, proudly confirms a remarkable achievement in the optimization of its vision correction technology - the Ocumetics Accommodating Lens. Through rigorous research and development efforts over the past two years, Ocumetics has modified its lens design five times, ultimately...Read more


Allurion Technologies Featured at the 2023 International Bariatric Club Oxford University World Congress

September 18
Last Trade: 5.47 0.06 1.11

Congress convenes the world’s leading bariatric healthcare professionals to discuss innovative therapies NATICK, Mass. / Sep 18, 2023 / Business Wire / Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced its participation in the 4th International Bariatric Club (IBC) Oxford World Congress, which takes place at Oxford University, September 18-20, 2023. The IBC event, entitled ‘Managing...Read more


RetinalGeniX Technologies Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases

September 18
Last Trade: 9.40 0.00 0.00

PETALUMA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) released to the public via OTC Markets, a video webinar regarding the retinal screening medical device technology being developed by the Company to help prevent blindness and multiple systemic diseases, the Company’s business opportunities and the professional background of the Company’s management...Read more


Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference

September 18
Last Trade: 0.39 -0.0001 -0.03

Loughborough, England, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present business updates and developments at the Maxim Group Emerging Growth in A.I., virtual conference. The presentation will...Read more


Biolase Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants

September 18
Last Trade: 1.74 0.03 1.75

LAKE FOREST, Calif., Sept. 18, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 75,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series J Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $100.00...Read more


Natera Announces Senior Leadership Appointments

September 18
Last Trade: 47.29 -1.87 -3.80

AUSTIN, Texas / Sep 18, 2023 / Business Wire / Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced three appointments within its senior leadership team, effective immediately. Solomon Moshkevich has been promoted to president of clinical diagnostics and will lead Natera’s team of general managers across oncology, women’s health, and organ health. In addition, Moshkevich will have responsibility for...Read more


Avricore Health: HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic

September 15
Last Trade: 0.21 0.00 0.00

VANCOUVER, British Columbia, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is expanding its innovative point-of-care chronic and infectious disease screening and health-data management platform, HealthTab™, further into the Canadian pharmacy ecosystem with one of Canada’s largest pharmacy retailers, Rexall Pharmacy Group ULC (“Rexall”). “With Pharmacies’...Read more


Biognosys Presents Technological Innovations and Scientific Progress to Make the Proteome Actionable for Life Science Research at the HUPO 2023 World Congress

September 15
Last Trade: 62.18 -1.98 -3.09

Library-free and machine learning-augmented data analysis with Spectronaut® 18 yields industry-leading protein quantification and throughput for DIA proteomics Novel collaborative research using the TrueDiscovery® and TrueTarget® CRO services platforms demonstrates the quantitative precision and wide applicability of mass spectrometry proteomics for biomarker discovery and drug development Biognosys’ iRT Kit is cornerstone of Bruker’s...Read more


Teleflex Selected to Exhibit Arrow™ VPS Rhythm™ DLX Device and Arrow™ PICCs preloaded with the NaviCurve™ Stylet at Vizient Innovative Technology Exchange

September 15
Last Trade: 203.42 -5.32 -2.55

WAYNE, Pa., Sept. 15, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has been selected to exhibit Arrow™ VPS Rhythm™ DLX Device and Arrow™ PICCs preloaded with the NaviCurve™ Stylet at the Vizient Innovative Technology Exchange. Vizient, Inc., the nation’s largest provider-driven healthcare performance improvement company, will hold the Exchange on Oct. 3...Read more


Prenetics Global Announces Second Quarter 2023 Financial Results

September 15
Last Trade: 0.47 -0.02 -4.08

HONG KONG, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics-driven health sciences company, today announced financial results for the second quarter ended June 30, 2023, along with recent business updates. Second Quarter 2023 Financial Highlights Revenue from continuing operations of US$5.7 million Adjusted EBITDA from continuing operations of US$(5.3)...Read more


Treace Medical Concepts Announces New Patent Covering Instrumented Bunion Correction Procedures and Milestone 50th U.S. Patent

September 14
Last Trade: 13.43 -0.46 -3.31

PONTE VEDRA, Fla., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction® Procedure, is pleased to announce the United States Patent and Trademark Office’s (USPTO) forthcoming issuance of U.S. Patent No....Read more


Venus Concept Receives 510(k) Clearance for the Venus Versa Pro System, Its New Multi-Application Platform

September 14
Last Trade: 2.02 -0.19 -8.65

TORONTO, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it has received a 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market its Venus Versa Pro System, the Company’s new multi-application platform, for a variety of aesthetic and cosmetic procedures. Venus Versa is a modular system based...Read more


A Clearer Vision of Surgery: Stryker Releases its Next-Generation of Advanced Surgical Cameras

September 14
Last Trade: 284.31 -4.66 -1.61

Stryker's 1788 camera platform brings enhanced technology to the operating room – including a wider color gamut, more vivid white light and new fluorescence imaging capabilities SAN JOSE, California, USA, Sept. 14, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's leading medical technology companies, today unveiled the next-generation of minimally invasive surgical cameras: the 1788 platform. The fully enhanced camera is...Read more


Charles River Laboratories and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica

September 14
Last Trade: 198.18 -10.45 -5.01

Logica, an offering from Charles River and Valo Health, will be used to discover first-in-class therapeutics against high value targets in the Related Sciences portfolio WILMINGTON, Mass. & DENVER / Sep 14, 2023 / Business Wire / Charles River Laboratories International, Inc. (NYSE: CRL) and Related Sciences (“RS”), a data science-driven drug discovery firm, today announced a multi-program collaboration agreement to apply Logica™...Read more


Natera Announces Expanded I-SPY 2 Collaboration to Evaluate Signatera™ for Breast Cancer Patients in the Neoadjuvant Setting

September 14
Last Trade: 47.29 -1.87 -3.80

Prospective study to monitor 600 patients in real time, across all subtypes of breast cancer AUSTIN, Texas / Sep 14, 2023 / Business Wire / Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study as part of the I-SPY 2 trial, sponsored and operated by Quantum Leap Healthcare Collaborative, that will use Signatera, Natera’s personalized and tumor-informed molecular residual disease (MRD) test,...Read more


Castle Biosciences: TissueCypher® Barrett’s Esophagus Test Outperformed Standard of Care in Risk-Stratifying Patients with Barrett’s Esophagus

September 14
Last Trade: 16.66 -0.28 -1.65

The study, published in Gastroenterology, shows TissueCypher can increase the detection of Barrett’s esophagus (BE) patients with an initial diagnosis of low-grade dysplasia (LGD) who will progress to high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC) FRIENDSWOOD, Texas / Sep 14, 2023 / Business Wire / Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today...Read more


Bionano Genomics: Largest Study of Mendelian Disease Highlights how OGM, alongside other Techniques, May Enhance Success Rates in Identifying Molecular Causes of Genetic Disease

September 14
Last Trade: 2.98 -0.02 -0.67

SAN DIEGO, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of a study detailing the challenges associated with the detection and interpretation of causal variants in Mendelian disease, using a cohort of 4,577 families. The study authors conducted a comprehensive analysis of samples from the cohort in which non-sequencing-based challenges were encountered, and then reanalyzed...Read more


Applied DNA Sciences Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals

September 14
Last Trade: 1.32 0.05 3.94

Agreement Focuses on the Accelerated Development of LNP-encapsulated LineaDNA™ Vaccines to Eliminate the Use of Plasmid DNA and Reduce the Dependence on Extreme Cold Chains of Today's mRNA Vaccines STONY BROOK, NY and ITHACA, NY / ACCESSWIRE / September 14, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (‘Applied DNA' or the "Company"), a leader in polymerase chain reaction ("PCR")-based technologies, and the Cornell University...Read more


LevelJump Healthcare Announces Update on Alberta Acquisitions and Preferred Share Unit Offering

September 14
Last Trade: 0.08 0.00 0.00

Toronto, Ontario--(Newsfile Corp. - September 14, 2023) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the "Company"), a Canadian leader in B2B telehealth solutions, wishes to announce the following: Alberta Acquisitions Update Further to its news releases of November 21, 2022, March 6 and July 5, 2023, the Company wishes to announce that it has settled the terms of a proposed debt facility with TD...Read more


Labcorp to Present Strategy, Business and Financial Outlook at Investor Day

September 14
Last Trade: 205.19 0.00 0.00

BURLINGTON, N.C., Sept. 14, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, is hosting an Investor Day beginning at 1:00 p.m. ET today in New York City, expected to conclude by approximately 4:00 p.m. ET. The event will highlight the company's go-forward strategy from Labcorp Chairman & CEO Adam Schechter, followed by business overviews and a longer-term financial...Read more


Henry Schein to Present at Goldman Sachs Global Sustainability Forum

September 14
Last Trade: 73.69 -0.78 -1.05

MELVILLE, N.Y. / Sep 14, 2023 / Business Wire / Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at Goldman Sachs Global Sustainability Forum in New York on September 27, 2023, at 12:15 p.m. Eastern time. Henry Schein’s presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts....Read more


Accuray to Host Investor Day at ASTRO on October 3, 2023

September 14
Last Trade: 2.70 -0.04 -1.46

MADISON, Wis., Sept. 14, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host a discussion with analysts and investors on Tuesday, October 3, 2023, in conjunction with the American Society of Radiation Oncology (ASTRO) Annual Meeting. The event will take place in person at the ASTRO meeting and on a virtual platform, with presentations beginning at 1:30 pm PT (4:30 pm ET). The Investor Day...Read more


Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase

September 14
Last Trade: 15.05 0.09 0.60

ATLANTA, Sept. 14, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present virtually at the upcoming Gilmartin Group Emerging Growth Company Showcase on Thursday, September 21, 2023.  The Company's presentation is scheduled to begin at 11:00 a.m. ET. A live webcast of the presentation will be accessible through Artivion's...Read more


ProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical Conferences

September 14
Last Trade: 1.00 0.03 3.06

PLEASANTON, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (“OSA”), today announced that their precision sleep apnea devices will be prominently featured in the scientific programs at upcoming medical conferences. The new scientific abstracts and podium presentations feature new data and additional data reporting on the efficacy,...Read more


HeartSciences Reports First Quarter Fiscal 2024 Financial Results

September 14
Last Trade: 0.37 -0.0074 -1.94

Southlake, TX, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today provided a business update and reported financial results for the first quarter fiscal 2024 ended July 31, 2023. Key...Read more


Mainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA Biomarkers, Reports Groundbreaking Topline Results Demonstrating Sensitivity for Colorectal Cancer of 94% with Specificity of 97% and Advanced Adenoma Sensitivity of 81%

September 13
Last Trade: 3.15 -0.10 -3.08

Multiple novel mRNA biomarkers identified for potential integration into pivotal FDA PMA clinical trial (ReconAAsense) BERKELEY, Calif. and MAINZ, Germany, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today positive topline results from its ColoFuture study. The ColoFuture study is...Read more


BARDA Partners With ICON to Execute Next Generation COVID-19 Vaccines Clinical Trial

September 13
Last Trade: 251.87 -9.91 -3.79

DUBLIN / Sep 13, 2023 / Business Wire / ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces that it is partnering with the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to execute a clinical trial to evaluate the effectiveness of...Read more


Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program

September 13
Last Trade: 0.39 -0.0001 -0.03

LOUGHBOROUGH, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced interim results from its metabolic health program. The primary objective of the study was to establish whether a metabolic program with a...Read more


Inspira™ Technologies Announces 510(k) FDA Submission of INSPIRA™ ART100 Towards Commercialization

September 13
Last Trade: 1.38 -0.05 -3.29

Management estimates FDA clearance within approximately 6 months RA'ANANA, Israel, Sept. 13, 2023 /PRNewswire/ -- Inspira™ Technologies OXY BHN Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira Technologies"), a company aiming to bring a paradigm shift to acute respiratory care by empowering breathing without lungs, announced it had submitted its INSPIRA ART 100, a cardio-pulmonary bypass device, to the U.S. Food and Drug...Read more


Sign Up To Get Daily Health Stock News

Please review our Disclaimer and Privacy Policy before subscribing.

Today's Medical Gainers

 
CompanyChangeLast Trade
Zynex 0.34 4.23 $8.37
Varex Imaging 0.24 1.31 $18.54
Check-Cap 0.23 6.02 $4.05
InspireMD 0.22 6.96 $3.38
NRC Health 0.20 0.43 $46.78
OraSure Technologies 0.18 3.31 $5.61
Sientra 0.14 4.68 $3.13
TELA Bio 0.10 1.23 $8.20
Helius Medical Technologies 0.09 1.05 $8.67
DarioHealth 0.09 2.96 $3.13
Exagen 0.09 3.86 $2.42
Artivion 0.09 0.60 $15.05
TriSalus Life Sciences 0.09 1.64 $5.59
IceCure Medical 0.09 14.78 $0.66
Sight Sciences 0.08 2.78 $2.96

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

COPYRIGHT ©2023 HEALTH STOCKS HUB